Supporting people with type 2 diabetes in effective use of their medicine through a system comprising mobile health technology integrated with clinical care compared with usual care: a randomised controlled trial

niversity of Oxford0 个研究点目标入组 1,039 人开始时间: 2020年9月18日最近更新: 2022年9月26日

适应症

试验速览

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35188478/ (added 22/02/2022)

•1. Willing and able to give informed consent for participation in the trial
•2. Aged =35 years
•3. Diagnosis of type 2 diabetes
•4. Taking oral glucose-lowering treatment, blood pressure-lowering treatment, or lipid-lowering treatment (diabetes treatments) either alone or in combination
•5. Has access to a UK registered mobile phone and is able, if necessary, with help (e.g. relative, friend, neighbour), to send, understand and retrieve brief SMS text-messages in the English language
•6. Registered with a general practice participating in the trial

•1. Pregnant, has been pregnant in the last three months or planning pregnancy during the course of the trial
•2. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant’s ability to participate in the trial
•3. Insulin treatment without concomitant use of oral glucose lowering treatment
•4. Admitted to hospital within the last three months for hyper- or hypoglycaemia (self-report)
•5. Another person in the household already participates in this trial
•6. Currently using a pharmacist managed monitored dosage system for supply of medication.

发起方